Preoperative and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantation.

PubWeight™: 1.50‹?› | Rank: Top 4%

🔗 View Article (PMID 15480173)

Published in Transplantation on October 15, 2004

Authors

Edmund Q Sanchez1, Thomas A Gonwa, Marlon F Levy, Robert M Goldstein, Martin L Mai, Steven R Hays, Larry B Melton, Giovanna Saracino, Goran B Klintmalm

Author Affiliations

1: Baylor Regional Transplant Institute, Dallas, Texas 75204, USA. EdmundS@baylorhealth.edu

Articles by these authors

Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med (2005) 4.05

Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl (2004) 3.46

Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression. Am J Respir Crit Care Med (2004) 2.93

Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension. Am J Respir Crit Care Med (2009) 2.19

Acute kidney injury following liver transplantation: definition and outcome. Liver Transpl (2009) 2.05

Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria. Ann Surg (2016) 2.05

Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study. Transplantation (2006) 1.94

Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality. J Infect Dis (2007) 1.78

Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation. Liver Transpl (2009) 1.69

Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis. Clin Infect Dis (2009) 1.60

Patients with NASH and cryptogenic cirrhosis are less likely than those with hepatitis C to receive liver transplants. Clin Gastroenterol Hepatol (2011) 1.57

Twenty years of follow-up of aortohepatic conduits in liver transplantation. Liver Transpl (2008) 1.53

Hepatorenal syndrome: pathophysiology and management. Clin J Am Soc Nephrol (2006) 1.50

Interobserver agreement in hepatitis C grading and staging and in the Banff grading schema for acute cellular rejection: the "hepatitis C 3" multi-institutional trial experience. Arch Pathol Lab Med (2006) 1.49

Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin. Transplantation (2009) 1.47

Development and validation of GFR-estimating equations using diabetes, transplant and weight. Nephrol Dial Transplant (2009) 1.46

Syndromic incidence of ovarian carcinoma after liver transplantation, with special reference to anteceding breast cancer. Dig Dis Sci (2003) 1.43

Results of a prospective randomized trial of sirolimus conversion in kidney transplant recipients on early corticosteroid withdrawal. Transplantation (2011) 1.42

Assessing water quality at large geographic scales: relations among land use, water physicochemistry, riparian condition, and fish community structure. Environ Manage (2003) 1.38

Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation. J Thorac Cardiovasc Surg (2007) 1.34

Does chronic microaspiration cause idiopathic pulmonary fibrosis? Am J Med (2010) 1.30

Modeling the allocation system: principles for robust design before restructuring. Transplantation (2015) 1.26

Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantation. Ann Surg (2002) 1.24

Chromatin-bound mitogen-activated protein kinases transmit dynamic signals in transcription complexes in beta-cells. Proc Natl Acad Sci U S A (2008) 1.23

Expansion of melanoma-specific cytolytic CD8+ T cell precursors in patients with metastatic melanoma vaccinated with CD34+ progenitor-derived dendritic cells. J Exp Med (2004) 1.22

Hepatocellular carcinoma: management of an increasingly common problem. Proc (Bayl Univ Med Cent) (2008) 1.20

Applying stereology to measure thickness of the basement membrane zone in bronchial biopsy specimens. J Allergy Clin Immunol (2003) 1.20

Large human islets secrete less insulin per islet equivalent than smaller islets in vitro. Islets (2011) 1.20

A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl (2003) 1.20

Improving efficacy of clinical islet transplantation with iodixanol-based islet purification, thymoglobulin induction, and blockage of IL-1β and TNF-α. Cell Transplant (2011) 1.18

Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation. Liver Transpl (2012) 1.18

An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients. Clin Infect Dis (2005) 1.14

Predicting renal failure after liver transplantation from measured glomerular filtration rate: review of up to 15 years of follow-up. Transplantation (2010) 1.13

Calcineurin/nuclear factor of activated T cells and MAPK signaling induce TNF-{alpha} gene expression in pancreatic islet endocrine cells. J Biol Chem (2010) 1.12

Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation. Part I. Liver Transpl (2002) 1.12

An outcome comparison between primary liver transplantation and retransplantation based on the pretransplant MELD score. Transpl Int (2006) 1.11

Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl (2007) 1.10

Cutaneous cryptococcosis in solid organ transplant recipients. Med Mycol (2010) 1.09

Iodixanol-controlled density gradient during islet purification improves recovery rate in human islet isolation. Transplantation (2009) 1.07

Allograft loss in renal transplant recipients with cryptococcus neoformans associated immune reconstitution syndrome. Transplantation (2005) 1.05

Pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis C. Am J Transplant (2003) 1.05

Differential regulation of CHOP-10/GADD153 gene expression by MAPK signaling in pancreatic beta-cells. Proc Natl Acad Sci U S A (2007) 1.04

Antifungal management practices and evolution of infection in organ transplant recipients with cryptococcus neoformans infection. Transplantation (2005) 1.02

Low-temperature preservation of isolated islets is superior to conventional islet culture before islet transplantation. Transplantation (2010) 1.01

Identification of patients best suited for combined liver-kidney transplantation: part II. Liver Transpl (2002) 1.01

De novo tumors after liver transplantation: a single-institution experience. Liver Transpl (2002) 1.00

Review of major clinical trials with mycophenolate mofetil in renal transplantation. Transplantation (2005) 1.00

Two-stage total hepatectomy and liver transplantation for acute deterioration of chronic liver disease: a new bridge to transplantation. Liver Transpl (2004) 1.00

Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study. Transplantation (2003) 1.00

Fresh islets are more effective for islet transplantation than cultured islets. Cell Transplant (2012) 1.00

Comparison of kidney function between donation after cardiac death and donation after brain death kidney transplantation. Transplantation (2013) 0.99

Liver transplantation in association with hepatocellular carcinoma: an update of the International Tumor Registry. Liver Transpl (2002) 0.99

Liver retransplantation for primary nonfunction: analysis of a 20-year single-center experience. Liver Transpl (2007) 0.99

Evaluation of osmolality of density gradient for human islet purification. Cell Transplant (2012) 0.99

Impact of pretransplant hyponatremia on outcome following liver transplantation. Hepatology (2009) 0.99

Liver and intestine transplantation. Am J Transplant (2004) 0.97

Pancreatic islet cell transplantation: a treatment strategy for type I diabetes mellitus. Nutr Clin Pract (2004) 0.96

Late acute rejection after liver transplantation impacts patient survival. Clin Transplant (2008) 0.96

Liver and kidney transplantation for polycystic liver and kidney-renal function and outcome. Transplantation (2006) 0.96

The role of mucus in fatal asthma. Am J Med (2003) 0.95

Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen. Clin Infect Dis (2008) 0.95

Unrecognized pretransplant and donor‐derived cryptococcal disease in organ transplant recipients. Clin Infect Dis (2010) 0.94

Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis. Antimicrob Agents Chemother (2007) 0.94

Variables associated with islet yield in autologous islet cell transplantation for chronic pancreatitis. Proc (Bayl Univ Med Cent) (2010) 0.94

Characterization of human pancreatic progenitor cells. Cell Transplant (2010) 0.93